Like a criminal entering a witness protection program, cancer cells can shed their past and take on a new identity. Detecting such an identity switch is particularly challenging when metastatic castration-resistant prostate ...
Jan 10, 2024
0
13
More than 65,000 men fall ill with prostate cancer each year in Germany. Of these, 12,000 develop a treatment-resistant form that eventually ends in death. Now, a team of researchers from the Medical Faculty at the University ...
Jan 9, 2024
0
2
Scientists at Nottingham Trent University wanted to investigate the anti-cancer properties of carnosine against cells derived from both primary and metastatic prostate cancer—where the cancer began and where it had spread ...
Jan 5, 2024
0
38
Prostate cancer is the most common cancer in men other than skin cancer, and more than 288,000 new cases are diagnosed every year, according to the American Cancer Society. The disease's fatality rate has decreased by more ...
Dec 21, 2023
0
11
Immunotherapy has been disappointing as a prostate cancer treatment, but a new Columbia study suggests that the powerful treatments have potential when the disease starts to spread.
Dec 12, 2023
0
47
Men with hormone-resistant prostate cancer and specific genetic mutations who were treated with the PARP inhibitor drug olaparib survived longer than men treated with traditional hormone therapy, according to an analysis ...
Dec 7, 2023
0
1
Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow—advancements that can help explain why some ...
Dec 4, 2023
0
47
As cancers grow and spread in the human body, they tend to become more aggressive over time, and this can accelerate during treatment as they develop resistance to drugs. In prostate cancers, some evolve into a rare, treatment-resistant ...
Nov 29, 2023
0
68
Men with a particular genetic subtype of the steroid biosynthesis enzyme HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer, according to new Cleveland Clinic-led research published ...
Nov 20, 2023
0
1
Queen Mary University of London researchers have discovered a new immune mechanism in osteocytes, the most common type of bone cell, that could lead to new drugs for breast and prostate cancer.
Nov 17, 2023
0
35
